Top Markets
Coin of the day
Oruka Therapeutics, Inc. Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc.

ORKA
Clasificación en acciones #3144
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
Precio por acción
$100.91
Última sincronización: 2026-08-25
Capitalización bursátil
$6.09B
Cambio (1 día)
-1.47%
Cambio (1 año)
581.36%
País
US
Comercio Oruka Therapeutics, Inc. (ORKA)

Categoría

Historial del precio de la acción de Oruka Therapeutics, Inc. (ORKA)
Precio más alto de cierre: $106.09 el 2026-08-01

Precio más bajo de cierre: $4.84M el 1997-12-01
Historial del precio de la acción de Oruka Therapeutics, Inc. desde 1997 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 58.23%
2025 42.90%
2024 -0.16%
2023 -22.61%
2022 -0.72%
2021 -45.08%
2020 -24.36%
2019 -28.32%
2018 -68.07%
2017 -46.86%
2016 -51.59%
2015 -15.86%
2014 -43.56%
2013 -26.26%
2012 -71.67%
2011 -61.96%
2010 8.83%
2009 -51.11%
2008 -84.91%
2007 -76.28%
2006 3.31%
2005 -17.12%
2004 -4.50%
2003 257.05%
2002 -86.09%
2001 -11.58%
1999 76.44%
1998 -48.78%
1997 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$122.98 -12.01%
AU
$772.27 7.33%
CH